Zanubrutinib-d5 (BGB-3111-d5), a deuterium-labeled Zanubrutinib, is an orally available Brutons tyrosine kinase inhibitor for the study of B-cell malignancies.
Molecular Weight:
476.58
Purity:
>99.99%
Formula:
C27H29N5O3
Target:
BTK
TMIH-0610
* VAT and and shipping costs not included. Errors and price changes excepted